 NRx Pharmaceuticals NASDAQ: NRXP identifies a statistically significant effect of Zyesami aviptadil in preventing the sharp rise in cytokines, commonly associated with mortality in patients with COVID-19. Data will be presented at the Disease Control and Prevention Summit on July 21 at 10:10 E.T. 